BAX and cancer: Cyclin D1, an oncogene that promotes cell cycle progression through phosphorylation of the retinoblastoma protein and prevents apoptosis by sequestering Bax in the cytoplasm has been recognized as a potential therapeutic target in cancer [33], [34].